Web Marketing
Common sense approach to Internet marketing guidelines
It’s amazing that PhRMA would come up with recommended guidelines that seem to be developed over a cup of coffee rather than really think about how consumers use and need health information online. The people at PhRMA need to contact the sales people at Manhattan Research to get updated information before they pull ideas out of space.
Read the full storyPhRMA Recommended guidelines for drug Internet Marketing but who speaks for patients ?
J&J asked that companies not be held responsible for user comments they do not control. This is needed and should be accepted practice
Read the full storySocial Health 2010 (SXSH)
Wow, it’s been a loooong time since I last published a blog post! So, what have I been up to that’s kept me so busy? Well, let’s just say I’ve been working on a few new things that have kept me pretty occupied… Firstly, I recently moved into a new role at work at the start of the year, I’m now officially part of the Marketing (brand) team leading digital strategy and social media. That responsibility came with a bunch of new deadlines and travel, that have made Q1 2010 the busiest quarter I’ve had since I joined the company… but definitely in a good, good way (like a caffeine high )! On top of all that, I have also been working with a few key folks ( Dana Lewis , Reed Smith , and Tom Stitt ) to bring together a special Health Care and Social Media (HCSM) event just prior to the largest international Social Media gathering at South by South West (SXSW)… The event is called: Social Health 2010 ( SXSH ) and it will be held on March 11th, 2010 at the Texas Hospital Association in Austin, TX
Data-Driven Relationships
Maximizing data to drive brand loyalty and sales.
Cultivating relationships with both physicians and patients is a critical part of the marketing process for pharma as you need HCPs to prescribe drugs and patients to stay compliant on them. So, making an investment in those relationships, including how they are tracked and measured is key.
Conceptually, this [...]
sanofi aventis Feels the Social Media Pain. But Is It Authentic?
Simultaneous posts on Pharmalot and Pharma bnet have focused on what seems to be a disgruntled patient who posted photos and comments on sanofi-aventis’s (S-A) Facebook page (see ” Bald Women Lash Out At Sanofi-Aventis & Taxotere ” and ” Sanofi’s Latest Challenge: Women Who Say Its Chemotherapy Left Them Permanently Bald “). “Ann Adams” posted this message to S-A’s Facebook Wall: “Good morning Sanofi, i had your drug Taxotere and as you can see from me photo this is what my scalp looks like 4 years later. Do you have any comment to make?” Her bald head photo appears on S-A’s Facebook page as well
Read the full storyMerck Says FDA Should Approve the “One-Click Rule”
Merck submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools ( find it here ). About 75% of Merck’s comments that specifically address FDA’s questions is devoted to an argument in favor of the “one-click rule” as it applies to space-limited digital product ads.
Read the full storyHow Did Pfizer Get So Many Twitter Followers?
Wow! Pfizer’s official Twitter account, @pfizer_news (” The official site for Pfizer Inc., where we apply science and our global resources to improve health and well-being at every stage of life.”) has over 5,000 followers, making it the MOST followed pharma Twitter account! And just this last December it had less than 1,000 followers (see chart below). How did Pfizer get so many followers so quickly?
Read the full storyPfizer Asks for New FDA Regulations, Not Guidance, for Social Media
Pfizer submitted comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here ). The world’s #1 pharmaceutical company stands alone in calling upon the FDA to develop new regulations for the Internet and social media rather than issuing guidance that puts an “interpretative gloss” on existing rules
Read the full storyPatientsLikeMe Reports High Rate of Adverse Event Reporting Among Its Members
Content marketing: When will the drug industry get it ?
Although marketing is changing because of new consumer behavior one aspect of marketing remains the same: go where your audience is. While there are more and more people using the Web for health information there has also been an explosion of health sites and social media on the Internet. There are, for example, over 1,000 pages of health related information on Facebook.
Read the full story









Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice